| GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
|
[BP] GO:0042221 |
response to chemical
|
ADRA2A, AKR1B1, ALPL, APEX1, AXL, BCL2, CA2, CES1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESRRA, FABP3, FABP4, FLT3, GRIK5, GRM5, HSD17B2, IGF1R, KCNH2, KDR, MAOB, MMP2, MMP9, PPARA, RORC, SLC6A2, SLC6A3, SLC6A4, SRC, TERT, TYR |
9.30245 |
|
[BP] GO:0007193 |
None
|
ADORA1, ADRA2A, CHRM2, DRD2, DRD3, DRD4, GRM1, GRM3, GRM5, GRM8 |
8.8577 |
|
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, APEX1, AXL, BCL2, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, ESR1, ESRRA, FABP3, GRIK5, GRM5, HSD17B2, IGF1R, MAOB, MMP2, MMP9, PPARA, RORC, SLC6A3, SLC6A4, SRC, TYR |
8.77438 |
|
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, ADRA2A, AKR1B1, APEX1, AURKB, AXL, BCL2, CA12, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, ESR1, FABP3, FABP4, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM5, HCAR2, HSD17B2, KCNH2, KDR, MAOB, MET, PPARA, SLC1A1, SLC6A2, SLC6A3, SLC6A4, SRC, TERT, XDH |
8.77438 |
|
[BP] GO:0010033 |
response to organic substance
|
ADRA2A, AKR1B1, ALPL, APEX1, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESRRA, FABP3, FABP4, FLT3, GRIK5, GRM5, HSD17B2, IGF1R, KDR, MAOB, MMP2, PPARA, RORC, SLC6A3, SLC6A4, SRC, TYR |
8.43902 |
|
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, APEX1, AXL, BCL2, CES1, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, KDR, MAOB, SLC6A3, SLC6A4, SRC |
8.34902 |
|
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, APEX1, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, FABP4, KDR, MAOB, MMP9, SLC6A3, SRC, TERT |
7.71182 |
|
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, APEX1, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESRRA, FLT3, MAOB, RORC, SLC6A3, SLC6A4, SRC, TYR |
7.65767 |
|
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, ADRA2A, AKR1B1, APEX1, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CYP19A1, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, GRIK5, GRM1, GRM5, HCAR2, IGF1R, KCNH2, KDR, MAOB, MET, MMP1, MMP12, MMP2, MMP9, PDE5A, PIM1, PPARA, PTPN1, RORC, SLC6A4, SRC, TERT, TOP2A, XDH |
7.48823 |
|
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, ADRA2A, AKR1B1, APEX1, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CYP19A1, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, HCAR2, IGF1R, KCNH2, KDR, MAOB, MET, MMP1, MMP12, MMP2, MMP9, PDE5A, PIM1, PPARA, PTPN1, RORC, SLC1A1, SLC6A3, SLC6A4, SRC, TERT, TOP2A, XDH |
7.41723 |
|
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, CA2, CA7, DRD2, DRD3, DRD4, GRIK5, GRM1, GRM3, GRM5, GRM8, SLC6A4 |
7.01958 |
|
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, CA2, CA7, DRD2, DRD3, DRD4, GRIK5, GRM1, GRM3, GRM5, GRM8, SLC6A4 |
7.01958 |
|
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, ADRA2A, AKR1B1, AKR1B10, ALOX5, ALPL, AXL, BCL2, CYP19A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESRRB, FABP4, GRM1, GRM5, GRM8, HSD17B2, IGF1R, KCNH2, MET, MMP1, MMP12, MMP2, MMP9, PDE5A, PIM1, PPARA, RORC, SLC6A2, SLC6A3, SLC6A4, SRC, TYR |
6.72271 |
|
[BP] GO:0007215 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
6.57497 |
|
[BP] GO:0007188 |
None
|
ADORA1, ADRA2A, CHRM2, DRD2, DRD3, DRD4, GRM1, GRM3, GRM5, GRM8 |
6.51016 |
|
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, BCL2, CES1, CYP19A1, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, FDPS, MAOB, SLC6A3, TYR |
6.46825 |
|
[BP] GO:0042592 |
homeostatic process
|
ADORA1, ADRA2A, AKR1B1, APEX1, AXL, BCL2, CA12, CA2, CA7, DRD2, DRD3, DRD4, ESR1, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, KCNH2, MET, SRC, TERT |
6.38297 |
|
[BP] GO:0018958 |
None
|
AKR1B1, BCL2, DRD2, DRD3, DRD4, MAOB, SLC6A3, TYR |
6.38297 |
|
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, TYR |
6.20456 |
|
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, ALPL, APEX1, AURKB, AXL, BCL2, CA2, CES1, CHRM2, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESRRA, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, HSD17B2, IGF1R, KCNH2, KDR, MAOB, MMP12, MMP2, MMP9, PPARA, PTPN1, RORC, SLC6A2, SLC6A3, SLC6A4, SRC, TERT, TOP2A, TYR |
5.9954 |
|
[BP] GO:0042493 |
response to drug
|
AKR1B1, APEX1, AXL, BCL2, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, FABP3, KCNH2, KDR, MAOB, SLC6A2, SLC6A3, SLC6A4, SRC |
5.97119 |
|
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX5, AOX1, CA1, CA12, CA2, CA4, CA7, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, FDPS, FUT7, GLO1, PDE5A, PIM1, PPARA, TYR, XDH |
5.97119 |
|
[BP] GO:0007187 |
None
|
ADORA1, ADRA2A, CHRM2, DRD2, DRD3, DRD4, GRM1, GRM3, GRM5, GRM8 |
5.95628 |
|
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, CES1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, FDPS, HSD17B2 |
5.8856 |
|
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DRD2, ESR1, FABP3, FABP4, FDPS, FUT7, HSD17B2, MET, PPARA |
5.8856 |
|
[BP] GO:0070887 |
cellular response to chemical stimulus
|
ADRA2A, AKR1B1, ALPL, APEX1, AXL, BCL2, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, GRIK5, GRM5, IGF1R, KCNH2, KDR, MMP2, MMP9, RORC, SLC6A4, SRC, TERT |
5.78104 |
|
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, DRD2, DRD3, DRD4, GRIK5, MAOB, SLC1A1, SLC6A2, SLC6A3, SLC6A4 |
5.78009 |
|
[BP] GO:0043271 |
negative regulation of ion transport
|
ADORA1, ADRA2A, BCL2, DRD2, DRD3, DRD4, KCNH2, MAOB, MMP9 |
5.78009 |
|
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, ADRA2A, AKR1B1, BCL2, CDC25B, CYP1B1, DRD2, DRD3, ESR1, ESRRA, FABP3, FLT3, IGF1R, KDR, MMP12, MMP2, MMP9, PDE5A, PIM1, SLC6A4, SRC, TERT, XDH |
5.75336 |
|
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, ADRA2A, AKR1B1, AXL, BCL2, CA2, CA7, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, FLT3, GRM1, HCAR2, KDR, MET, MMP12, MMP9, PDE5A, PTPN1, SRC, TERT, XDH |
5.70118 |
|
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, ADRA2A, AKR1B1, AXL, BCL2, CA2, CA7, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, FLT3, GRM1, HCAR2, KDR, MET, MMP12, MMP9, PDE5A, PTPN1, SRC, TERT, XDH |
5.67522 |
|
[BP] GO:0033993 |
response to lipid
|
ALPL, AXL, BCL2, CA2, CYP1A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HSD17B2, MAOB, RORC, SLC6A4, SRC, TYR |
5.37217 |
|
[BP] GO:1900543 |
None
|
ADRA2A, DRD2, DRD3, DRD4, GRM3, GRM8, PPARA |
5.37217 |
|
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, DRD2, DRD3, DRD4, ESR1, PPARA, RORC, SLC6A4, SRC, TOP2A |
5.37217 |
|
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, ADRA2A, AKR1B1, AURKB, AXL, BCL2, CA2, CA7, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, FLT3, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, MET, MMP12, MMP9, PDE5A, PTPN1, SLC6A4, SRC, TERT, XDH |
5.37217 |
|
[BP] GO:0045980 |
None
|
ADRA2A, DRD2, DRD3, DRD4, GRM3, GRM8, PPARA |
5.35443 |
|
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, APEX1, AURKB, AXL, BCL2, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, GRM3, GRM8, IGF1R, KCNH2, KDR, MAOB, MET, MMP12, MMP9, PDE5A, PIM1, PPARA, PTPN1, RORC, SLC6A4, SRC, TERT, TOP2A, XDH |
5.28746 |
|
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, ADRA2A, AKR1B1, AURKB, AXL, BCL2, CA2, CA7, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, FLT3, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, MET, MMP12, MMP9, PDE5A, PTPN1, SLC6A4, SRC, TERT, XDH |
5.28746 |
|
[BP] GO:0006584 |
None
|
AKR1B1, DRD2, DRD3, DRD4, MAOB, SLC6A3 |
5.28746 |
|
[BP] GO:0009712 |
None
|
AKR1B1, DRD2, DRD3, DRD4, MAOB, SLC6A3 |
5.28746 |
|
[BP] GO:0030818 |
None
|
ADRA2A, DRD2, DRD3, DRD4, GRM3, GRM8 |
5.25266 |
|
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7 |
5.25266 |
|
[BP] GO:0009719 |
response to endogenous stimulus
|
ADRA2A, AKR1B1, ALPL, APEX1, BCL2, CA2, CYP1A2, ESR1, ESRRA, FABP3, FLT3, GRM5, IGF1R, MAOB, MMP2, PPARA, SLC6A4, SRC |
5.17944 |
|
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, APEX1, AURKB, AXL, BCL2, CYP1B1, ESR1, FLT3, GLO1, GRIK5, HCAR2, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTPN1, SRC, TERT, TOP2A, XDH |
5.17944 |
|
[BP] GO:0030803 |
None
|
ADRA2A, DRD2, DRD3, DRD4, GRM3, GRM8 |
5.16133 |
|
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, APEX1, AURKB, AXL, BCL2, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, GRM3, GRM8, HCAR2, IGF1R, KCNH2, KDR, MAOB, MET, MMP12, MMP9, PDE5A, PIM1, PPARA, PTPN1, RORC, SLC6A3, SLC6A4, SRC, TERT, TOP2A, XDH |
5.16133 |
|
[BP] GO:0009725 |
response to hormone
|
ADRA2A, AKR1B1, ALPL, APEX1, BCL2, CA2, CYP1A2, ESR1, ESRRA, FABP3, FLT3, MAOB, PPARA, SLC6A4, SRC |
5.16133 |
|
[BP] GO:0007196 |
None
|
GRM1, GRM3, GRM5, GRM8 |
5.10534 |
|
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, APEX1, AURKB, AXL, BCL2, CYP1B1, ESR1, FLT3, GLO1, GRIK5, HCAR2, IGF1R, KDR, MET, MMP9, PIM1, PTPN1, SRC, TERT, TOP2A, XDH |
5.10534 |
|
[BP] GO:0030815 |
None
|
ADRA2A, DRD2, DRD3, DRD4, GRM3, GRM8 |
5.08676 |
|
[BP] GO:1900372 |
None
|
ADRA2A, DRD2, DRD3, DRD4, GRM3, GRM8 |
5.05615 |
|
[BP] GO:0030809 |
None
|
ADRA2A, DRD2, DRD3, DRD4, GRM3, GRM8 |
5.05615 |
|
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, ADRA2A, APEX1, AXL, BCL2, CA2, CA7, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, GRIK5, GRM5, HCAR2, IGF1R, KCNH2, KDR, MAOB, MET, MMP12, MMP9, PPARA, PTPN1, SLC6A4, SRC, TERT |
5.04789 |
|
[BP] GO:0030800 |
None
|
ADRA2A, DRD2, DRD3, DRD4, GRM3, GRM8 |
5.01965 |
|
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
4.95462 |
|
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, DRD2, DRD3, DRD4, FABP3, PPARA, SLC1A1 |
4.85245 |
|
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ADRA2A, BCL2, CDC25B, DRD2, DRD3, DRD4, ESRRB, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MMP9, PDE5A, PPARA, PTPN1, SRC, XDH |
4.83669 |
|
[BP] GO:0042417 |
None
|
DRD2, DRD3, DRD4, MAOB, SLC6A3 |
4.79567 |
|
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ADRA2A, BCL2, CDC25B, DRD2, DRD3, DRD4, ESRRB, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MMP9, PDE5A, PPARA, PTPN1, SRC, XDH |
4.79567 |
|
[BP] GO:0048878 |
chemical homeostasis
|
ADRA2A, AKR1B1, BCL2, CA12, CA2, CA7, DRD2, DRD3, DRD4, ESR1, FABP3, FABP4, GRIK5, GRM1, GRM5, KCNH2, MET |
4.79567 |
|
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AOX1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DRD2, DRD3, DRD4, MAOB, SLC6A3 |
4.69819 |
|
[BP] GO:0071310 |
cellular response to organic substance
|
ADRA2A, AKR1B1, ALPL, APEX1, AXL, BCL2, CYP1A1, CYP1B1, ESR1, FABP4, FLT3, GRIK5, GRM5, IGF1R, KDR, MMP2, RORC, SLC6A4, SRC |
4.67298 |
|
[BP] GO:0042752 |
None
|
ADORA1, DRD2, DRD3, DRD4, PPARA, RORC, TOP2A |
4.67043 |
|
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, DRD2, GRM1, GRM3, GRM5, GRM8 |
4.65784 |
|
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, APEX1, AURKB, AXL, BCL2, CYP1B1, ESR1, FLT3, GLO1, GRIK5, HCAR2, IGF1R, KDR, MMP9, PIM1, PTPN1, SRC, TERT, TOP2A, XDH |
4.61414 |
|
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, ADRA2A, CYP1A1, DRD3, FABP3, FDPS, FLT3, HCAR2, PPARA, RORC, SRC |
4.5789 |
|
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CDC25B, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FDPS, FLT3, FUT7, GLO1, HSD17B2, IGF1R, KCNH2, KDR, MAOB, MET, MMP1, MMP12, MMP2, MMP9, PDE5A, PIM1, PPARA, PTPN1, RORC, SLC6A3, SLC6A4, SRC, TERT, TOP2A, TYR, XDH |
4.5789 |
|
[BP] GO:0051716 |
cellular response to stimulus
|
ADRA2A, AKR1B1, ALPL, APEX1, AURKB, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, GRIK5, GRM1, GRM5, IGF1R, KCNH2, KDR, MMP2, MMP9, PTPN1, RORC, SLC6A4, SRC, TERT, TOP2A |
4.54387 |
|
[BP] GO:0007194 |
None
|
ADRA2A, DRD2, DRD3, DRD4, GRM3 |
4.5437 |
|
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APEX1, DRD2, DRD3, DRD4, FABP3, FLT3, GRM5, IGF1R, MMP2, PPARA, SLC6A3, SLC6A4, SRC, TYR |
4.5314 |
|
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AOX1, AURKB, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, FABP4, FUT7, MAOB, MMP1, MMP12, MMP2, MMP9, PDE5A, SLC6A3, SRC, XDH |
4.50568 |
|
[BP] GO:0007268 |
None
|
CHRM2, DRD2, DRD3, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2 |
4.50568 |
|
[BP] GO:0098916 |
None
|
CHRM2, DRD2, DRD3, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2 |
4.50568 |
|
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, ALPL, APEX1, AURKB, AXL, BCL2, CA2, CDC25B, CES1, CHRM2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, GLO1, HSD17B2, KDR, MAOB, MET, MMP2, MMP9, PIM1, PPARA, RORC, SLC6A3, SLC6A4, SRC, TERT, TOP2A, TYR |
4.44219 |
|
[BP] GO:0031280 |
None
|
ADRA2A, DRD2, DRD3, DRD4, GRM3 |
4.44093 |
|
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CDC25B, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FDPS, FLT3, FUT7, GLO1, HSD17B2, IGF1R, KCNH2, KDR, MAOB, MET, MMP1, MMP2, PDE5A, PIM1, PPARA, PTPN1, RORC, SLC6A3, SLC6A4, SRC, TERT, TOP2A, TYR, XDH |
4.43559 |
|
[BP] GO:0099536 |
None
|
CHRM2, DRD2, DRD3, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2 |
4.43559 |
|
[BP] GO:0099537 |
None
|
CHRM2, DRD2, DRD3, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2 |
4.43559 |
|
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, ADRA2A, AXL, BCL2, CA2, CA7, CYP19A1, DRD2, DRD3, DRD4, GRIK5, GRM5, HCAR2, KCNH2, MAOB, MMP12, MMP9, PPARA, PTPN1, SLC6A4, SRC, TERT |
4.43398 |
|
[BP] GO:0007216 |
None
|
GRM1, GRM3, GRM5, GRM8 |
4.43398 |
|
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ADRA2A, AURKB, BCL2, CDC25B, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, GRM1, GRM5, IGF1R, KDR, MAOB, MET, MMP12, MMP9, PDE5A, PPARA, PTPN1, RORC, SRC, TERT, TOP2A, XDH |
4.4183 |
|
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.38833 |
|
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7 |
4.35566 |
|
[BP] GO:0051350 |
None
|
ADRA2A, DRD2, DRD3, DRD4, GRM3 |
4.35566 |
|
[BP] GO:1900542 |
None
|
ADRA2A, DRD2, DRD3, DRD4, ESRRB, GRM3, GRM8, PDE5A, PPARA |
4.34521 |
|
[BP] GO:0006805 |
xenobiotic metabolic process
|
CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, RORC |
4.34029 |
|
[BP] GO:0006811 |
None
|
CA1, CA12, CA14, CA2, CA4, CA7, DRD2, DRD3, DRD4, FABP3, GRIA2, GRIA4, GRIK5, KCNH2, PPARA, SLC1A1, SLC6A2, SLC6A3, SLC6A4 |
4.34029 |
|
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ADRA2A, AURKB, BCL2, CDC25B, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, GRM1, GRM5, IGF1R, KDR, MAOB, MET, MMP12, MMP9, PDE5A, PPARA, PTPN1, RORC, SLC6A4, SRC, TERT, TOP2A, XDH |
4.26385 |
|
[BP] GO:0006140 |
None
|
ADRA2A, DRD2, DRD3, DRD4, ESRRB, GRM3, GRM8, PDE5A, PPARA |
4.25197 |
|
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CDC25B, CES1, CES2, CHRM2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FDPS, FLT3, FUT7, GLO1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSD17B2, IGF1R, KCNH2, KDR, MAOB, MET, MMP1, MMP12, MMP2, MMP9, PDE5A, PIM1, PPARA, PTPN1, RORC, SLC1A1, SLC6A2, SLC6A3, SLC6A4, SRC, TERT, TOP2A, TYR, XDH |
4.25193 |
|
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PIM1, PPARA, RORC, SRC |
4.24676 |
|
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ADRA2A, AURKB, BCL2, CDC25B, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, FLT3, GRM1, GRM5, IGF1R, KDR, MAOB, MET, MMP12, MMP9, PDE5A, PPARA, PTPN1, RORC, SRC, TERT, TOP2A, XDH |
4.24405 |
|
[BP] GO:0010038 |
response to metal ion
|
BCL2, CA2, CYP1A1, CYP1A2, DRD2, FABP4, MAOB, MMP9, SLC6A3, TERT |
4.24077 |
|
[BP] GO:0032225 |
None
|
DRD2, DRD3, DRD4, SLC6A4 |
4.24031 |
|
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APEX1, DRD2, DRD3, DRD4, FABP3, FLT3, GRM5, IGF1R, MMP2, PPARA, SLC6A3, SLC6A4, SRC, TYR |
4.21571 |
|
[BP] GO:0043269 |
regulation of ion transport
|
ADORA1, ADRA2A, BCL2, CA2, CA7, DRD2, DRD3, DRD4, GRM5, KCNH2, MAOB, MMP9, SLC6A4 |
4.15995 |
|
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, AKR1B10, DRD2, DRD3, DRD4, MAOB, SLC6A3 |
4.14467 |
|
[BP] GO:0001504 |
None
|
SLC1A1, SLC6A2, SLC6A3, SLC6A4 |
4.14208 |
|
[BP] GO:0060078 |
None
|
ADORA1, DRD4, GRIA2, GRIA4, GRIK5, GRM5 |
4.12297 |
|
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, ADRA2A, AXL, BCL2, CA2, CYP19A1, DRD2, DRD3, DRD4, HCAR2, KCNH2, MMP12, SLC6A4, SRC, TERT |
4.10015 |
|
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DRD2, FABP3, FABP4, FDPS, FUT7, MET, PPARA |
4.09741 |
|
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, ADRA2A, AKR1B1, AXL, BCL2, CYP1B1, DRD2, DRD3, DRD4, FLT3, GRM1, KDR, MET, MMP12, MMP9, PDE5A, PTPN1, SRC, TERT, XDH |
4.06611 |
|
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ADRA2A, BCL2, CDC25B, DRD2, DRD4, ESRRB, FABP3, FLT3, GRM1, GRM5, KDR, MMP9, PDE5A, PTPN1, SRC, XDH |
4.05672 |
|
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ADRA2A, BCL2, CDC25B, DRD2, DRD4, ESRRB, FABP3, FLT3, GRM1, GRM5, KDR, MMP9, PDE5A, PTPN1, SRC, XDH |
4.05672 |
|
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, BCL2, CYP1A1, DRD2, MMP2, PPARA, SLC6A4, SRC, TERT |
4.05672 |
|
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, ADRA2A, AKR1B1, AXL, BCL2, CYP1B1, DRD2, DRD4, FLT3, GRM1, KDR, MET, PDE5A, PTPN1, SRC, XDH |
4.04511 |
|
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC, SRC |
4.03699 |
|
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, ADRA2A, BCL2, CDC25B, DRD2, DRD4, ESRRB, FLT3, GRM1, GRM5, KDR, MMP9, PDE5A, PTPN1, SRC, XDH |
3.98428 |
|
[BP] GO:1904063 |
None
|
ADRA2A, DRD2, DRD3, DRD4, KCNH2, MMP9 |
3.97587 |
|
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, ADRA2A, AXL, BCL2, CA2, CHRM2, CYP1B1, DRD2, DRD3, ESR1, ESRRA, ESRRB, GRM1, HCAR2, KCNH2, KDR, MET, MMP12, MMP9, PDE5A, PIM1, SLC1A1, SLC6A3, SLC6A4, SRC, TERT, XDH |
3.97566 |
|
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, BCL2, CYP1A1, DRD2, MMP2, PPARA, SLC6A4, SRC, TERT |
3.97566 |
|
[BP] GO:0045761 |
None
|
ADRA2A, DRD2, DRD3, DRD4, GRM3 |
3.97566 |
|
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, ADRA2A, AURKB, BCL2, CDC25B, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, FLT3, GRM1, GRM5, IGF1R, KDR, MET, MMP12, MMP9, PDE5A, PPARA, PTPN1, RORC, SLC6A4, SRC, TERT, TOP2A, XDH |
3.9391 |
|
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, ADRA2A, AKR1B1, AXL, BCL2, CA1, CA2, CHRM2, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KCNH2, KDR, MET, MMP2, MMP9, PDE5A, PIM1, PPARA, PTPN1, RORC, SRC |
3.90993 |
|
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, DRD2, DRD3, DRD4, FABP3, PPARA, SLC1A1 |
3.90947 |
|
[BP] GO:0008284 |
positive regulation of cell proliferation
|
ADRA2A, AKR1B1, BCL2, CDC25B, DRD2, DRD3, ESR1, FLT3, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1, TERT |
3.89179 |
|
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, ADRA2A, APEX1, BCL2, CYP19A1, CYP1B1, DRD2, DRD3, IGF1R, KDR, MET, MMP9, SRC, TERT |
3.85792 |
|
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, ADRA2A, APEX1, BCL2, CYP19A1, CYP1B1, DRD2, IGF1R, KDR, MET, MMP9, SRC, TERT |
3.85715 |
|
[BP] GO:0051934 |
None
|
SLC6A2, SLC6A3, SLC6A4 |
3.85715 |
|
[BP] GO:0090494 |
None
|
SLC6A2, SLC6A3, SLC6A4 |
3.85715 |
|
[BP] GO:0090493 |
None
|
SLC6A2, SLC6A3, SLC6A4 |
3.85715 |
|
[BP] GO:0051583 |
None
|
SLC6A2, SLC6A3, SLC6A4 |
3.85715 |
|
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
3.84214 |
|
[BP] GO:0030799 |
None
|
ADRA2A, DRD2, DRD3, DRD4, GRM3, GRM8, PDE5A |
3.83795 |
|
[BP] GO:0051588 |
None
|
DRD2, DRD3, DRD4, GRIK5, MAOB, SLC6A4 |
3.81804 |
|
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, BCL2, CA2, CA7, DRD2, DRD3, KDR, SRC |
3.81294 |
|
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, ADRA2A, AURKB, CYP1B1, DRD2, DRD3, DRD4, ESR1, FABP4, GRM3, IGF1R, MET, MMP9, PIM1, PPARA, PTPN1, SRC |
3.79007 |
|
[BP] GO:1903530 |
regulation of secretion by cell
|
ACHE, ADORA1, ADRA2A, CYP19A1, DRD2, DRD3, DRD4, GRIK5, HCAR2, MAOB, MMP12, SLC6A4, SRC |
3.72229 |
|
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, BCL2, CYP1A1, DRD2, MMP2, PPARA, SLC6A4, SRC, TERT |
3.72229 |
|
[BP] GO:0034766 |
None
|
ADRA2A, DRD2, DRD3, DRD4, KCNH2, MMP9 |
3.72229 |
|
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, ADRA2A, AURKB, BCL2, CA2, CA7, DRD2, DRD3, HCAR2, KDR, SRC |
3.69736 |
|
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, PPARA |
3.67282 |
|
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
3.65466 |
|
[BP] GO:0098810 |
None
|
SLC6A2, SLC6A3, SLC6A4 |
3.65398 |
|
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1, MAOB |
3.63589 |
|
[BP] GO:0030817 |
None
|
ADRA2A, DRD2, DRD3, DRD4, GRM3, GRM8 |
3.63589 |
|
[BP] GO:0023052 |
None
|
ADORA1, CHRM2, DRD2, DRD3, ESR2, GRIA2, GRIK5, GRM1, GRM3, GRM5, KCNH2, SLC1A1, SLC6A2 |
3.63544 |
|
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, ADRA2A, BCL2, CDC25B, DRD2, DRD4, FLT3, GRM1, GRM5, KDR, MMP9, PDE5A, PTPN1, SRC, XDH |
3.59448 |
|
[BP] GO:0034763 |
None
|
ADRA2A, DRD2, DRD3, DRD4, KCNH2, MMP9 |
3.5933 |
|
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, ADRA2A, APEX1, BCL2, CYP19A1, CYP1B1, DRD2, IGF1R, KDR, MET, MMP9, SRC, TERT |
3.5933 |
|
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ADRA2A, BCL2, CDC25B, DRD2, DRD4, ESRRB, FABP4, FLT3, GRM1, GRM5, IGF1R, KDR, MMP9, PDE5A, PPARA, PTPN1, SRC, XDH |
3.5877 |
|
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, GLO1, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTPN1, SRC, TERT |
3.57587 |
|
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, ADRA2A, AKR1B1, AURKB, AXL, BCL2, CYP1B1, DRD2, DRD3, DRD4, ESR1, FLT3, GRM1, IGF1R, KDR, MET, MMP9, PDE5A, PTPN1, SRC, XDH |
3.56925 |
|
[BP] GO:0042391 |
None
|
ADORA1, BCL2, DRD4, GRIA2, GRIA4, GRIK5, GRM5, KCNH2, KDR, SRC |
3.53031 |
|
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
3.50855 |
|
[BP] GO:0051940 |
None
|
DRD2, DRD3, DRD4 |
3.48883 |
|
[BP] GO:0050665 |
hydrogen peroxide biosynthetic process
|
CYP1A1, CYP1A2, MAOB |
3.48883 |
|
[BP] GO:0051584 |
None
|
DRD2, DRD3, DRD4 |
3.48883 |
|
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ADRA2A, AXL, BCL2, CA2, CYP1B1, DRD2, DRD3, ESRRB, HCAR2, KDR, MET, MMP12, MMP9, PDE5A, PIM1, SLC1A1, SLC6A3, SRC, TERT |
3.48423 |
|
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, ADRA2A, AKR1B1, AXL, BCL2, CYP1B1, DRD2, DRD3, DRD4, ESRRA, FABP4, FLT3, GRM1, KDR, MET, MMP12, MMP2, MMP9, PDE5A, PTPN1, SRC, TERT, XDH |
3.4835 |
|
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, ADRA2A, AKR1B1, CYP19A1, CYP1A1, CYP1B1, DRD2, ESR1, HCAR2, HSD17B2 |
3.45973 |
|
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FDPS |
3.4546 |
|
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC, SRC |
3.45003 |
|
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, ADRA2A, DRD2, DRD4, FLT3, GRM1, KDR, PDE5A, PTPN1, SRC, XDH |
3.45003 |
|
[BP] GO:0051046 |
None
|
ACHE, ADORA1, ADRA2A, CYP19A1, DRD2, DRD3, DRD4, GRIK5, HCAR2, MAOB, MMP12, SLC6A4, SRC |
3.44631 |
|
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, BCL2, CYP1B1, SRC |
3.44631 |
|
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B2 |
3.44631 |
|
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, APEX1, AXL, CYP1B1, MMP9, SRC |
3.44631 |
|
[BP] GO:0031279 |
None
|
ADRA2A, DRD2, DRD3, DRD4, GRM3 |
3.44211 |
|
[BP] GO:0045860 |
positive regulation of protein kinase activity
|
ADORA1, ADRA2A, CDC25B, DRD2, DRD4, FLT3, GRM1, GRM5, PDE5A, PTPN1, SRC |
3.44076 |
|
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, ADRA2A, APEX1, AURKB, BCL2, CDC25B, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FDPS, FLT3, GLO1, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, MAOB, MET, MMP12, MMP9, PDE5A, PIM1, PPARA, PTPN1, RORC, SLC6A3, SLC6A4, SRC, TERT, TOP2A, XDH |
3.42867 |
|
[BP] GO:0051339 |
None
|
ADRA2A, DRD2, DRD3, DRD4, GRM3 |
3.41738 |
|
[BP] GO:0007267 |
None
|
ADORA1, CHRM2, DRD2, DRD3, ESR2, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2 |
3.41531 |
|
[BP] GO:0044057 |
None
|
ADORA1, ADORA3, ADRA2A, CHRM2, DRD2, DRD3, GRM1, HCAR2, KCNH2, PDE5A, SLC1A1 |
3.41307 |
|
[BP] GO:0007154 |
None
|
ADORA1, AXL, BCL2, CHRM2, DRD2, DRD3, ESR2, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2 |
3.38785 |
|
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, GLO1, IGF1R, KDR, MET, MMP9, PIM1, PTPN1, SRC, TERT |
3.38785 |
|
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, APEX1, AXL, BCL2, CYP1B1, MMP9, SRC |
3.3678 |
|
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, AURKB, BCL2, CA2, CYP1A1, DRD2, DRD3, GRM1, MMP2, PPARA, SLC6A4, SRC, TERT, TYR |
3.36322 |
|
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APEX1, AXL, CYP1B1, ESR1, GRIK5, GRM5, IGF1R, MMP2, MMP9, RORC, SLC6A4, SRC |
3.35218 |
|
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, ADRA2A, BCL2, DRD2, DRD3, ESR1, ESR2, IGF1R, MET, MMP12, MMP9, PTPN1, SLC6A4, SRC, TERT, XDH |
3.34634 |
|
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, ADRA2A, BCL2, DRD2, DRD3, ESR1, ESR2, IGF1R, MET, MMP12, MMP9, PTPN1, SLC6A4, SRC, TERT, XDH |
3.33028 |
|
[BP] GO:0030814 |
None
|
ADRA2A, DRD2, DRD3, DRD4, GRM3, GRM8 |
3.30106 |
|
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, ADRA2A, DRD4, FLT3, GRM1, IGF1R, PDE5A, PTPN1, SRC |
3.28536 |
|
[BP] GO:0015908 |
None
|
DRD2, DRD3, DRD4, FABP3, PPARA |
3.27605 |
|
[BP] GO:0045744 |
None
|
ADRA2A, DRD2, DRD3, MET |
3.27452 |
|
[BP] GO:0010039 |
response to iron ion
|
BCL2, CYP1A1, DRD2, SLC6A3 |
3.27452 |
|
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, ADRA2A, APEX1, BCL2, CYP19A1, CYP1B1, DRD2, IGF1R, KDR, MET, MMP9, SRC, TERT |
3.27025 |
|
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX5, AOX1, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, HSD17B2, MAOB, TYR, XDH |
3.26108 |
|
[BP] GO:0030802 |
None
|
ADRA2A, DRD2, DRD3, DRD4, GRM3, GRM8 |
3.25245 |
|
[BP] GO:0007195 |
None
|
DRD2, DRD3, DRD4 |
3.23863 |
|
[BP] GO:2001225 |
regulation of chloride transport
|
CA2, CA7, GRM5 |
3.23863 |
|
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, CA2, CA7, DRD2 |
3.23113 |
|
[BP] GO:0033674 |
positive regulation of kinase activity
|
ADORA1, ADRA2A, CDC25B, DRD2, DRD4, FLT3, GRM1, GRM5, PDE5A, PTPN1, SRC |
3.22967 |
|
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B2 |
3.22949 |
|
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, APEX1, CYP1A1, CYP1B1, ESR1, FLT3, RORC, SLC6A4, SRC |
3.19861 |
|
[BP] GO:0043406 |
positive regulation of MAP kinase activity
|
ADORA1, ADRA2A, DRD4, FLT3, GRM1, PDE5A, PTPN1, SRC |
3.19852 |
|
[BP] GO:0050801 |
ion homeostasis
|
BCL2, CA12, CA2, CA7, DRD2, DRD3, DRD4, ESR1, FABP3, GRM1, GRM5, KCNH2 |
3.17352 |
|
[BP] GO:0048513 |
animal organ development
|
ACHE, AXL, BCL2, CA2, CYP19A1, CYP1A1, CYP1A2, ESR1, ESRRA, ESRRB, FLT3, HSD17B2, KDR, PPARA, SRC, TYR |
3.17352 |
|
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADORA1, ADRA2A, CDC25B, DRD2, DRD4, FABP4, FLT3, GRM1, GRM5, IGF1R, PDE5A, PTPN1, SRC |
3.17352 |
|
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ADRA2A, BCL2, CYP19A1, DRD2, DRD3, ESR1, ESR2, IGF1R, MET, MMP12, MMP9, PPARA, PTPN1, SLC6A3, SRC, TERT, XDH |
3.1536 |
|
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FDPS |
3.15338 |
|
[BP] GO:0034776 |
None
|
DRD2, DRD3, DRD4 |
3.1236 |
|
[BP] GO:0051347 |
positive regulation of transferase activity
|
ADORA1, ADRA2A, AURKB, CDC25B, DRD2, DRD4, FLT3, GRM1, GRM5, PDE5A, PTPN1, SRC |
3.08403 |
|
[BP] GO:1900371 |
None
|
ADRA2A, DRD2, DRD3, DRD4, GRM3, GRM8 |
3.08195 |
|
[BP] GO:0032413 |
None
|
ADRA2A, DRD2, DRD3, DRD4, MMP9 |
3.07866 |
|
[BP] GO:0030808 |
None
|
ADRA2A, DRD2, DRD3, DRD4, GRM3, GRM8 |
3.06721 |
|
[BP] GO:0051952 |
None
|
ADORA1, ADRA2A, DRD2, DRD3, DRD4 |
3.05912 |
|
[BP] GO:0045787 |
positive regulation of cell cycle
|
APEX1, AURKB, CDC25B, CYP1A1, DRD2, DRD3, SLC6A4, SRC, TERT |
3.03783 |
|
[BP] GO:0015872 |
None
|
SLC6A2, SLC6A3, SLC6A4 |
3.02086 |
|
[BP] GO:0032467 |
None
|
AURKB, CDC25B, DRD2, DRD3 |
3.01624 |
|
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, ADRA2A, BCL2, CDC25B, DRD2, DRD4, FABP4, FLT3, GRM1, GRM5, IGF1R, KDR, MMP9, PDE5A, PTPN1, SRC, XDH |
3.00222 |
|
[BP] GO:1903522 |
None
|
ADORA1, ADORA3, ADRA2A, CHRM2, DRD2, KCNH2, PDE5A, SLC1A1 |
2.99537 |
|
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, ADRA2A, APEX1, AURKB, BCL2, CDC25B, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FDPS, FLT3, GLO1, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, MAOB, MET, MMP12, MMP9, PDE5A, PIM1, PPARA, PTPN1, RORC, SLC6A3, SRC, TERT, TOP2A, XDH |
2.99054 |
|
[BP] GO:0032787 |
None
|
ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, GLO1, PPARA |
2.98778 |
|
[BP] GO:0043393 |
regulation of protein binding
|
AURKB, BCL2, MET, MMP9, PPARA, SRC, TERT |
2.98778 |
|
[BP] GO:0045936 |
None
|
ADRA2A, DRD2, DRD3, DRD4, FABP4, GRM3, GRM8, IGF1R, PPARA, PTPN1, XDH |
2.96218 |
|
[BP] GO:0010563 |
None
|
ADRA2A, DRD2, DRD3, DRD4, FABP4, GRM3, GRM8, IGF1R, PPARA, PTPN1, XDH |
2.95858 |
|
[BP] GO:0051047 |
None
|
ACHE, ADORA1, CYP19A1, DRD2, DRD3, HCAR2, MMP12, SLC6A4, SRC |
2.95858 |
|
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.94133 |
|
[BP] GO:0060134 |
None
|
DRD2, DRD3, SLC6A3 |
2.93301 |
|
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, ADRA2A, DRD2, DRD4, FLT3, GRM1, IGF1R, KDR, PDE5A, PTPN1, SRC, XDH |
2.92388 |
|
[BP] GO:0032410 |
None
|
ADRA2A, DRD2, DRD3, DRD4, MMP9 |
2.90499 |
|
[BP] GO:0043549 |
regulation of kinase activity
|
ADORA1, ADRA2A, CDC25B, DRD2, DRD4, FABP4, FLT3, GRM1, GRM5, IGF1R, PDE5A, PTPN1, SRC |
2.89288 |
|
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, GLO1, IGF1R, KDR, MMP9, PIM1, PTPN1, SRC, TERT |
2.86226 |
|
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.83904 |
|
[BP] GO:0051580 |
None
|
DRD2, DRD3, DRD4 |
2.83904 |
|
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, ADRA2A, AURKB, BCL2, CDC25B, DRD2, DRD4, ESR1, ESR2, FLT3, GRM1, GRM5, MET, MMP9, PDE5A, PTPN1, SRC, TERT, XDH |
2.839 |
|
[BP] GO:0045934 |
None
|
ADRA2A, APEX1, AURKB, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, FABP4, GRM3, GRM8, MMP12, PPARA, RORC, SRC, TERT |
2.8333 |
|
[BP] GO:0045776 |
None
|
ADORA1, DRD2, DRD3, PPARA |
2.83239 |
|
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, ADRA2A, APEX1, AURKB, BCL2, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, FABP4, GRM3, GRM8, HCAR2, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PTPN1, RORC, SRC, TERT, XDH |
2.82945 |
|
[BP] GO:0007200 |
None
|
ADRA2A, CHRM2, DRD2, ESR1, GRM5 |
2.82111 |
|
[BP] GO:0042133 |
neurotransmitter metabolic process
|
ACHE, CYP1B1, MAOB, SLC6A3, SLC6A4 |
2.79852 |
|
[BP] GO:0061098 |
None
|
ADORA1, ADRA2A, GRM5, PTPN1 |
2.79741 |
|
[BP] GO:0051937 |
None
|
SLC6A2, SLC6A3, SLC6A4 |
2.75882 |
|
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, ADRA2A, AURKB, CDC25B, DRD2, DRD4, FABP4, FLT3, GRM1, GRM5, IGF1R, PDE5A, PTPN1, SRC |
2.74914 |
|
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
BCL2, DRD2, DRD3, ESR1, IGF1R, MET, MMP9, PTPN1, SRC, XDH |
2.74648 |
|
[BP] GO:0022898 |
None
|
ADRA2A, BCL2, DRD2, DRD3, DRD4, GRM5, MMP9 |
2.73408 |
|
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, ALPL, AXL, BCL2, CA2, CHRM2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, ESR1, ESRRA, ESRRB, FLT3, HSD17B2, KDR, MAOB, MMP9, PIM1, PPARA, RORC, SLC6A3, SRC, TYR |
2.72337 |
|
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, ADRA2A, AURKB, BCL2, CDC25B, DRD2, DRD3, DRD4, ESR1, FABP4, FLT3, GRM1, GRM3, GRM5, IGF1R, MMP9, PDE5A, PTPN1, SRC, TERT, XDH |
2.71932 |
|
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
2.70605 |
|
[BP] GO:0042136 |
neurotransmitter biosynthetic process
|
ACHE, CYP1B1, SLC6A3, SLC6A4 |
2.69636 |
|
[BP] GO:0098771 |
inorganic ion homeostasis
|
BCL2, CA12, CA2, CA7, DRD2, DRD3, DRD4, ESR1, GRM1, GRM5, KCNH2 |
2.68711 |
|
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.68627 |
|
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, BCL2, CDC25B, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FDPS, FLT3, FUT7, GLO1, HSD17B2, IGF1R, KCNH2, KDR, MAOB, MET, MMP1, MMP12, MMP2, MMP9, PDE5A, PIM1, PPARA, PTPN1, RORC, SLC6A3, SRC, TERT, TOP2A, TYR, XDH |
2.68062 |
|
[BP] GO:0065007 |
biological regulation
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, APEX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA7, CDC25B, CHRM2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FDPS, FLT3, GLO1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSD17B2, IGF1R, KCNH2, KDR, MAOB, MET, MMP1, MMP12, MMP2, MMP9, PDE5A, PIM1, PPARA, PTPN1, RORC, SLC1A1, SLC6A2, SLC6A3, SLC6A4, SRC, TERT, TOP2A, XDH |
2.66255 |
|
[BP] GO:0008016 |
None
|
ADORA1, ADORA3, CHRM2, DRD2, KCNH2, PDE5A, SLC1A1 |
2.6413 |
|
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
2.63867 |
|
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA3, AXL, BCL2, CA1, DRD2, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, MMP2, MMP9, PTPN1, SRC |
2.61498 |
|
[BP] GO:1901617 |
organic hydroxy compound biosynthetic process
|
AKR1B1, CES1, CYP19A1, FDPS, SLC6A3, TYR |
2.61269 |
|
[BP] GO:0022900 |
electron transport chain
|
AKR1B1, AOX1, CYP19A1, CYP1A2, MAOB, XDH |
2.61269 |
|
[BP] GO:0032409 |
None
|
ADRA2A, BCL2, DRD2, DRD3, DRD4, GRM5, MMP9 |
2.59072 |
|
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, ADRA2A, BCL2, CDC25B, DRD2, DRD4, FLT3, GRM1, GRM5, KDR, MMP9, PDE5A, PTPN1, SRC, XDH |
2.5555 |
|
[BP] GO:0034762 |
None
|
ADRA2A, BCL2, CA2, DRD2, DRD3, DRD4, GRM5, KCNH2, MMP9 |
2.54782 |
|
[BP] GO:0072593 |
reactive oxygen species metabolic process
|
BCL2, CYP1A1, CYP1A2, CYP1B1, MAOB |
2.53683 |
|
[BP] GO:0099566 |
None
|
GRM1, GRM5 |
2.53683 |
|
[BP] GO:0051944 |
None
|
DRD2, DRD4 |
2.53683 |
|
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.53683 |
|
[BP] GO:0060160 |
None
|
DRD2, DRD3 |
2.53683 |
|
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.53683 |
|
[BP] GO:0051586 |
None
|
DRD2, DRD4 |
2.53683 |
|
[BP] GO:0050994 |
None
|
ADORA1, ADRA2A, HCAR2, PPARA |
2.51666 |
|
[BP] GO:0015909 |
None
|
DRD2, DRD3, DRD4, FABP3 |
2.49093 |
|
[BP] GO:0045187 |
None
|
ADORA1, DRD2, DRD3 |
2.49093 |
|
[BP] GO:0042069 |
None
|
DRD4, MAOB, SLC6A3 |
2.49093 |
|
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.49093 |
|
[BP] GO:0042053 |
None
|
DRD4, MAOB, SLC6A3 |
2.49093 |
|
[BP] GO:0050731 |
positive regulation of peptidyl-tyrosine phosphorylation
|
ADORA1, ADRA2A, FLT3, GRM5, PTPN1, SRC |
2.48484 |
|
[BP] GO:0003008 |
None
|
ADORA1, ADRA2A, AKR1B1, BCL2, CYP1B1, DRD2, DRD3, GRM1, GRM5, GRM8, KCNH2, PDE5A, SLC6A3, SLC6A4, SRC, TYR |
2.48097 |
|
[BP] GO:0002791 |
None
|
ACHE, ADORA1, ADRA2A, DRD2, DRD3, DRD4, HCAR2, MMP12, SRC |
2.47842 |
|
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
2.4704 |
|
[BP] GO:0071902 |
positive regulation of protein serine/threonine kinase activity
|
ADORA1, ADRA2A, DRD4, FLT3, GRM1, PDE5A, PTPN1, SRC |
2.46076 |
|
[BP] GO:0032922 |
None
|
DRD2, DRD3, PPARA, RORC |
2.44146 |
|
[BP] GO:0048148 |
None
|
DRD2, DRD3, DRD4 |
2.43861 |
|
[BP] GO:0035813 |
None
|
ADORA1, DRD2, DRD3 |
2.43861 |
|
[BP] GO:0002521 |
leukocyte differentiation
|
AXL, BCL2, FLT3, FUT7, GLO1, MMP9, RORC |
2.42888 |
|
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, BCL2, CYP1A1, DRD2, PPARA |
2.42071 |
|
[BP] GO:0007626 |
None
|
DRD2, DRD3, DRD4, GRM1, GRM5, SLC6A3 |
2.42071 |
|
[BP] GO:0030336 |
None
|
ADORA1, ADORA3, APEX1, BCL2, CYP19A1, CYP1B1, DRD2 |
2.39368 |
|
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, ADRA2A, AURKB, BCL2, CDC25B, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, FABP4, FLT3, GRM1, GRM3, GRM5, IGF1R, MET, MMP9, PDE5A, PIM1, PPARA, PTPN1, SRC, TERT, XDH |
2.38429 |
|
[BP] GO:0015844 |
None
|
SLC6A2, SLC6A3, SLC6A4 |
2.38429 |
|
[BP] GO:0042749 |
None
|
ADORA1, DRD2, DRD3 |
2.38429 |
|
[BP] GO:0043085 |
positive regulation of catalytic activity
|
ADORA1, ADRA2A, AURKB, BCL2, CDC25B, DRD2, DRD4, ESR1, FLT3, GRM1, GRM5, PDE5A, PTPN1, SRC, TERT, XDH |
2.37756 |
|
[BP] GO:1903531 |
None
|
ADORA1, ADRA2A, DRD2, DRD3, DRD4, MAOB |
2.36445 |
|
[BP] GO:0042737 |
drug catabolic process
|
ACHE, CYP1A2, CYP2C19, MAOB, SLC6A3 |
2.35147 |
|
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4 |
2.35147 |
|
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.3422 |
|
[BP] GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation
|
MMP2, MMP9, TERT |
2.33173 |
|
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.33173 |
|
[BP] GO:0050995 |
None
|
ADORA1, ADRA2A, HCAR2 |
2.33173 |
|
[BP] GO:0090068 |
positive regulation of cell cycle process
|
APEX1, AURKB, CDC25B, CYP1A1, DRD2, DRD3, TERT |
2.31762 |
|
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.30995 |
|
[BP] GO:0007186 |
G-protein coupled receptor signaling pathway
|
ADORA1, ADORA3, ADRA2A, CA2, CHRM2, DRD2, DRD3, DRD4, ESR1, GRM1, GRM3, GRM5, GRM8, HCAR2, SRC |
2.30606 |
|
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1 |
2.29995 |
|
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.29995 |
|
[BP] GO:0051582 |
None
|
DRD2, DRD4 |
2.29995 |
|
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.29995 |
|
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, GLO1, PIM1, PPARA, TYR |
2.29525 |
|
[BP] GO:0051953 |
None
|
ADORA1, ADRA2A, DRD2 |
2.29375 |
|
[BP] GO:1903963 |
None
|
DRD2, DRD3, DRD4 |
2.29375 |
|
[BP] GO:0044062 |
None
|
ADORA1, DRD2, DRD3 |
2.29375 |
|
[BP] GO:0050482 |
None
|
DRD2, DRD3, DRD4 |
2.29375 |
|
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.29375 |
|
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA1, ADORA3, ADRA2A, APEX1, AURKB, BCL2, CDC25B, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GLO1, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MAOB, MET, MMP12, MMP9, PDE5A, PIM1, PPARA, PTPN1, RORC, SLC6A3, SRC, TERT, TOP2A, XDH |
2.2936 |
|
[BP] GO:2000146 |
None
|
ADORA1, ADORA3, APEX1, BCL2, CYP19A1, CYP1B1, DRD2 |
2.28147 |
|
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, APEX1, AXL, CYP1B1, KDR |
2.27708 |
|
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALPL, APEX1, AURKB, AXL, BCL2, CDC25B, DRD2, FDPS, FLT3, IGF1R, KCNH2, KDR, MET, PDE5A, PIM1, PTPN1, SRC, XDH |
2.27623 |
|
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, APEX1, AXL, CYP1B1, MMP9, SRC |
2.27349 |
|
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, APEX1, AXL, CYP1B1, KCNH2, KDR, SRC |
2.26797 |
|
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, CA2, CA7, DRD2, DRD4 |
2.26461 |
|
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
ADRA2A, APEX1, AURKB, BCL2, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, FABP4, GRM3, GRM8, IGF1R, MET, MMP12, MMP9, PPARA, PTPN1, RORC, SRC, TERT, XDH |
2.26047 |
|
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, FLT3, IGF1R, KDR, PIM1, SRC |
2.25583 |
|
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B2 |
2.25185 |
|
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, ADORA1, DRD2, SLC6A4 |
2.24654 |
|
[BP] GO:0051051 |
negative regulation of transport
|
ADORA1, ADRA2A, BCL2, DRD2, DRD3, DRD4, KCNH2, MAOB, MMP9 |
2.24148 |
|
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PTPN1, SRC |
2.22578 |
|
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.22578 |
|
[BP] GO:0051926 |
negative regulation of calcium ion transport
|
ADRA2A, BCL2, DRD2, DRD4 |
2.22578 |
|
[BP] GO:0050789 |
regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, APEX1, AURKB, AXL, BCL2, CA1, CA2, CA7, CDC25B, CHRM2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FDPS, FLT3, GLO1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KCNH2, KDR, MAOB, MET, MMP1, MMP12, MMP2, MMP9, PDE5A, PIM1, PPARA, PTPN1, RORC, SLC1A1, SLC6A3, SLC6A4, SRC, TERT, TOP2A, XDH |
2.22304 |
|
[BP] GO:0051171 |
regulation of nitrogen compound metabolic process
|
ADORA1, ADORA3, ADRA2A, APEX1, AURKB, BCL2, CDC25B, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GLO1, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MAOB, MET, MMP12, MMP9, PDE5A, PIM1, PPARA, PTPN1, RORC, SLC6A3, SRC, TERT, TOP2A, XDH |
2.2073 |
|
[BP] GO:0071900 |
regulation of protein serine/threonine kinase activity
|
ADORA1, ADRA2A, DRD4, FLT3, GRM1, IGF1R, PDE5A, PTPN1, SRC |
2.20319 |
|
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CES1, CYP19A1, FDPS, HSD17B2 |
2.19839 |
|
[BP] GO:0014910 |
regulation of smooth muscle cell migration
|
APEX1, BCL2, SRC, TERT |
2.18207 |
|
[BP] GO:0040014 |
regulation of multicellular organism growth
|
BCL2, DRD2, DRD3, SLC6A3 |
2.18207 |
|
[BP] GO:0055080 |
cation homeostasis
|
BCL2, CA2, CA7, DRD2, DRD3, DRD4, ESR1, GRM1, GRM5, KCNH2 |
2.17615 |
|
[BP] GO:0009968 |
negative regulation of signal transduction
|
ADRA2A, BCL2, DRD2, DRD3, ESR1, ESR2, IGF1R, MET, MMP12, MMP9, PTPN1, SRC, TERT, XDH |
2.16886 |
|
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, ADRA2A, AKR1B1, AURKB, AXL, BCL2, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, FABP4, FLT3, GRM1, IGF1R, KDR, MET, MMP12, MMP2, MMP9, PDE5A, PPARA, PTPN1, SLC6A3, SRC, TERT, XDH |
2.16884 |
|
[BP] GO:0006352 |
DNA-templated transcription, initiation
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
2.16884 |
|
[BP] GO:0035235 |
None
|
GRIA2, GRIA4, GRIK5 |
2.16744 |
|
[BP] GO:0032309 |
None
|
DRD2, DRD3, DRD4 |
2.16744 |
|
[BP] GO:0001975 |
None
|
DRD2, DRD3, DRD4 |
2.16744 |
|
[BP] GO:0051271 |
None
|
ADORA1, ADORA3, APEX1, BCL2, CYP19A1, CYP1B1, DRD2 |
2.16718 |
|
[BP] GO:0032465 |
None
|
AURKB, CDC25B, DRD2, DRD3 |
2.16669 |
|
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, CYP19A1, GLO1 |
2.14412 |
|
[BP] GO:0060079 |
None
|
ADORA1, GRIA2, GRIA4, GRIK5 |
2.14412 |
|
[BP] GO:0098657 |
import into cell
|
ACHE, ADORA1, AXL, DRD2, DRD3, SLC1A1, SLC6A2, SLC6A3, SLC6A4 |
2.13692 |
|
[BP] GO:0051048 |
None
|
ADORA1, ADRA2A, DRD2, DRD3, DRD4, MAOB |
2.13444 |
|
[BP] GO:0042321 |
None
|
ADORA1, DRD2 |
2.13444 |
|
[BP] GO:0090325 |
None
|
DRD2, DRD3 |
2.13444 |
|
[BP] GO:0015718 |
None
|
DRD2, DRD3, DRD4, FABP3, PPARA |
2.12588 |
|
[BP] GO:0022414 |
reproductive process
|
AKR1B1, ALPL, AXL, BCL2, CDC25B, CYP19A1, CYP1A1, ESR1, ESRRB, HSD17B2, MMP2, MMP9, SLC6A4, SRC, TOP2A |
2.1248 |
|
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, DRD2, DRD3, MET, SRC, XDH |
2.11743 |
|
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, ADRA2A, BCL2, CDC25B, DRD2, DRD4, ESR1, FLT3, GRM1, GRM5, KDR, MMP9, PDE5A, PTPN1, SRC, XDH |
2.08146 |
|
[BP] GO:0007623 |
circadian rhythm
|
DRD2, DRD3, PPARA, RORC, SLC6A4 |
2.07136 |
|
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD2, DRD3, ESR1, FABP4, KDR, MET, MMP12, PPARA, SLC6A3 |
2.06839 |
|
[BP] GO:0055082 |
cellular chemical homeostasis
|
BCL2, CA2, CA7, DRD2, DRD3, DRD4, ESR1, GRIK5, GRM1, GRM5 |
2.0657 |
|
[BP] GO:0044243 |
multicellular organismal catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.0657 |
|
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALPL, APEX1, AURKB, AXL, BCL2, CDC25B, DRD2, FDPS, FLT3, IGF1R, KCNH2, KDR, MET, PDE5A, PIM1, PTPN1, SRC, XDH |
2.06536 |
|
[BP] GO:0040013 |
None
|
ADORA1, ADORA3, APEX1, BCL2, CYP19A1, CYP1B1, DRD2 |
2.06536 |
|
[BP] GO:0008283 |
cell proliferation
|
ACHE, AURKB, BCL2, CYP1A1, ESR1, FLT3, MET, PIM1, SRC, TYR |
2.0634 |
|
[BP] GO:0019725 |
cellular homeostasis
|
APEX1, BCL2, CA2, CA7, DRD2, DRD3, DRD4, ESR1, GRIK5, GRM1, GRM5 |
2.06046 |
|
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, AOX1, AURKB, AXL, BCL2, CDC25B, CYP1A1, CYP1A2, DRD2, DRD3, DRD4, ESR1, FLT3, FUT7, GLO1, IGF1R, KCNH2, KDR, MAOB, MET, MMP1, MMP12, MMP2, MMP9, PDE5A, PIM1, PPARA, PTPN1, SLC6A3, SRC, TOP2A, TYR, XDH |
2.06046 |
|
[BP] GO:0071715 |
None
|
DRD2, DRD3, DRD4 |
2.05221 |
|
[BP] GO:0051590 |
None
|
DRD2, DRD4, SLC6A4 |
2.05221 |
|
[BP] GO:1901571 |
None
|
DRD2, DRD3, DRD4 |
2.05221 |
|
[BP] GO:0061097 |
None
|
ADORA1, ADRA2A, GRM5, PTPN1 |
2.0519 |
|
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, BCL2, CA2, FLT3, MAOB, SRC |
2.04693 |
|
[BP] GO:0032147 |
activation of protein kinase activity
|
ADORA1, ADRA2A, DRD2, DRD4, GRM1, PTPN1, SRC |
2.04025 |
|
[BP] GO:1901575 |
None
|
ACHE, ADORA1, AKR1B10, AOX1, AURKB, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FUT7, MAOB, PDE5A, SLC6A3, XDH |
2.02425 |
|
[BP] GO:0032412 |
None
|
ADRA2A, DRD2, DRD3, DRD4, GRM5, MMP9 |
2.01887 |
|
[BP] GO:0007610 |
None
|
BCL2, DRD2, DRD3, DRD4, GRM1, GRM5, PPARA, SLC6A3, SLC6A4 |
2.01887 |
|
[BP] GO:0050708 |
None
|
ACHE, ADRA2A, DRD2, DRD3, DRD4, HCAR2, MMP12, SRC |
2.01755 |
|
[BP] GO:0035265 |
organ growth
|
BCL2, CYP19A1, ESR1 |
2.01755 |
|
[BP] GO:0042743 |
hydrogen peroxide metabolic process
|
CYP1A1, CYP1A2, MAOB |
2.01755 |
|
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, MMP2, MMP9, TERT |
2.01698 |
|
[BP] GO:0046717 |
None
|
DRD2, DRD3, DRD4, SLC1A1 |
2.00128 |
|
[BP] GO:0051302 |
None
|
AURKB, CDC25B, DRD2, DRD3, ESRRB |
2.00128 |
|
[BP] GO:0051902 |
negative regulation of mitochondrial depolarization
|
BCL2, SRC |
2.00128 |
|
[BP] GO:0046113 |
None
|
AOX1, XDH |
2.00128 |
|
[BP] GO:0032415 |
None
|
DRD3, DRD4 |
2.00128 |
|
[BP] GO:0021984 |
None
|
DRD2, SLC6A3 |
2.00128 |
|
[BP] GO:0016098 |
monoterpenoid metabolic process
|
CYP1A2, CYP2C19 |
2.00128 |
|
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, ADRA2A, AXL, CA4, CHRM2, DRD2, DRD3, DRD4, FLT3, GRIA2, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, SLC1A1, SLC6A2, SLC6A3, SLC6A4 |
5.28746 |
|
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA1, ADORA3, ADRA2A, AXL, CHRM2, DRD2, DRD3, DRD4, FLT3, GRIA2, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, SLC1A1, SLC6A2, SLC6A3, SLC6A4 |
5.0348 |
|
[CC] GO:0044456 |
None
|
ACHE, ADORA1, CHRM2, DRD2, DRD4, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, SLC6A3, SLC6A4, SRC |
4.94407 |
|
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, ADRA2A, ALPL, AXL, CA12, CA14, CA2, CA4, CHRM2, DRD2, DRD3, DRD4, ESR1, FLT3, GLO1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KCNH2, KDR, MET, MMP2, PIM1, PTPN1, SLC1A1, SLC6A2, SLC6A3, SLC6A4, SRC, TERT |
4.83669 |
|
[CC] GO:0098590 |
plasma membrane region
|
ADORA1, ADRA2A, CA2, CA4, CHRM2, DRD2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, MET, SLC1A1, SRC |
4.03699 |
|
[CC] GO:0044459 |
plasma membrane part
|
ADORA1, ADORA3, ADRA2A, AXL, CA2, CA4, CHRM2, DRD2, DRD3, DRD4, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KCNH2, KDR, MET, SLC1A1, SLC6A2, SLC6A3, SLC6A4, SRC |
4.00372 |
|
[CC] GO:0043005 |
None
|
ADORA1, CA2, CHRM2, DRD2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, SLC6A2, SLC6A3, SLC6A4, SRC |
3.74475 |
|
[CC] GO:0042734 |
None
|
GRIK5, GRM1, GRM3, GRM5, GRM8 |
3.41738 |
|
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ADRA2A, ALOX5, ALPL, AXL, BCL2, CA12, CA14, CA2, CA4, CHRM2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DRD2, DRD3, DRD4, ESR1, FLT3, FUT7, GLO1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSD17B2, IGF1R, KCNH2, KDR, MAOB, MET, MMP2, PIM1, PTPN1, SLC1A1, SLC6A2, SLC6A3, SLC6A4, SRC, TERT, TYR |
3.25245 |
|
[CC] GO:0044425 |
membrane part
|
ACHE, ADORA1, ADORA3, ADRA2A, ALPL, AXL, BCL2, CA12, CA14, CA2, CA4, CHRM2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DRD2, DRD3, DRD4, ESR1, FLT3, FUT7, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSD17B2, IGF1R, KCNH2, KDR, MAOB, MET, PTPN1, SLC1A1, SLC6A2, SLC6A3, SLC6A4, SRC, TYR |
3.06721 |
|
[CC] GO:0014069 |
None
|
ADORA1, DRD2, GRIK5, GRM1, GRM3, GRM5, SRC |
3.06721 |
|
[CC] GO:0099572 |
None
|
ADORA1, DRD2, GRIK5, GRM1, GRM3, GRM5, SRC |
3.06721 |
|
[CC] GO:0097060 |
None
|
CHRM2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
2.98175 |
|
[CC] GO:0098794 |
None
|
ADORA1, DRD2, DRD4, GRIA2, GRIA4, GRM3 |
2.74648 |
|
[CC] GO:0098793 |
None
|
ADORA1, CHRM2, DRD2, GRIK5, SLC6A3, SLC6A4 |
2.55615 |
|
[CC] GO:0042995 |
cell projection
|
ADORA1, AKR1B1, CA2, CHRM2, DRD2, DRD3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, SLC6A2, SLC6A3, SLC6A4, SRC |
2.48582 |
|
[CC] GO:0043197 |
None
|
ADORA1, DRD2, GRIA2, GRIA4, GRM3 |
2.29995 |
|
[CC] GO:0044309 |
None
|
ADORA1, DRD2, GRIA2, GRIA4, GRM3 |
2.27708 |
|
[CC] GO:0120025 |
None
|
ADORA1, AKR1B1, CA2, CHRM2, DRD2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, SLC6A2, SLC6A3, SLC6A4, SRC |
2.26047 |
|
[CC] GO:0097458 |
None
|
ADORA1, CA2, CHRM2, DRD2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, SLC6A2, SLC6A3, SLC6A4, SRC |
2.00613 |
|
[CC] GO:0005783 |
None
|
ADORA1, APEX1, BCL2, CA4, CES1, CES2, CYP19A1, FLT3, GRIK5, KDR, PTPN1, XDH |
2.00613 |
|
[CC] GO:0097443 |
sorting endosome
|
KDR, PTPN1 |
2.00128 |
|
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, AOX1, CA1, CA12, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, TYR, XDH |
10.9106 |
|
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, ADRA2A, AXL, CHRM2, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KCNH2, KDR, MET, PPARA, RORC |
8.8577 |
|
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, ADRA2A, AXL, CHRM2, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KCNH2, KDR, MET, PPARA, RORC |
7.9623 |
|
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FDPS, FLT3, GLO1, IGF1R, KDR, MAOB, MET, MMP1, MMP12, MMP2, MMP9, PDE5A, PIM1, PPARA, PTPN1, RORC, SLC1A1, SLC6A2, SLC6A3, SLC6A4, SRC, TERT, TOP2A, TYR, XDH |
7.89798 |
|
[MF] GO:0008066 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
7.89194 |
|
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, ALPL, AOX1, APEX1, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, FDPS, GLO1, MMP1, MMP12, MMP2, MMP9, PDE5A, PIM1, PPARA, PTPN1, RORC, SLC1A1, SLC6A2, SLC6A3, SLC6A4, TERT, TOP2A, TYR, XDH |
7.89194 |
|
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, ADRA2A, AXL, CHRM2, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KCNH2, KDR, MET, PPARA, RORC |
7.80169 |
|
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
7.7472 |
|
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, ADRA2A, AXL, CHRM2, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KCNH2, KDR, MET, PPARA, RORC |
7.30204 |
|
[MF] GO:0030594 |
None
|
CHRM2, DRD2, DRD3, DRD4, GRIA2, GRIA4, GRIK5, GRM1, GRM5 |
6.5679 |
|
[MF] GO:0046872 |
metal ion binding
|
ALOX5, ALPL, AOX1, APEX1, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, FDPS, GLO1, MMP1, MMP12, MMP2, MMP9, PDE5A, PIM1, PPARA, PTPN1, RORC, SLC1A1, SLC6A2, SLC6A3, SLC6A4, TERT, TOP2A, TYR, XDH |
5.95628 |
|
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA7, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP12, MMP2, MMP9, PPARA, PTPN1, RORC |
5.47126 |
|
[MF] GO:1901338 |
None
|
ADRA2A, DRD2, DRD3, DRD4, SLC6A3 |
5.35443 |
|
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CDC25B, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FDPS, FLT3, FUT7, GLO1, HSD17B2, IGF1R, KCNH2, KDR, MAOB, MET, MMP1, MMP12, MMP2, MMP9, PDE5A, PIM1, PTPN1, SRC, TERT, TOP2A, TYR, XDH |
5.28746 |
|
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA7 |
5.28746 |
|
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, ADRA2A, AXL, CHRM2, DRD2, DRD3, DRD4, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, MET |
5.10534 |
|
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, ADRA2A, AXL, CHRM2, DRD2, DRD3, DRD4, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, MET |
5.10534 |
|
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
5.05615 |
|
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
5.05615 |
|
[MF] GO:0005330 |
None
|
SLC6A2, SLC6A3, SLC6A4 |
4.84544 |
|
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
4.80376 |
|
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
4.65784 |
|
[MF] GO:0035240 |
None
|
DRD2, DRD3, DRD4, SLC6A3 |
4.5314 |
|
[MF] GO:0005506 |
iron ion binding
|
ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, XDH |
4.46681 |
|
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CHRM2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DRD2, DRD3, DRD4, FLT3, IGF1R, KDR, MET, PIM1, PPARA, SLC6A3, SLC6A4, SRC, TOP2A |
4.36106 |
|
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, ADRA2A, APEX1, ESRRB, FLT3, IGF1R, KDR, MMP12, MMP9, PPARA, PTPN1, SLC6A3, SLC6A4, SRC |
4.35672 |
|
[MF] GO:0070405 |
ammonium ion binding
|
ACHE, DRD2, DRD3, DRD4, SLC6A3, SLC6A4 |
4.24031 |
|
[MF] GO:0042802 |
identical protein binding
|
ACHE, ADRA2A, AOX1, BCL2, DRD2, DRD4, ESR1, ESR2, FLT3, GRIK5, IGF1R, KCNH2, KDR, MAOB, MET, MMP9, SLC6A4, TERT, TOP2A, TYR, XDH |
4.19585 |
|
[MF] GO:0016829 |
lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA7, GLO1 |
4.11854 |
|
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX5, AOX1, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, HSD17B2, MAOB, TYR, XDH |
4.09274 |
|
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, ADRA2A, APEX1, ESRRB, FLT3, IGF1R, KDR, MMP12, MMP9, PIM1, PPARA, PTPN1, SLC6A3, SLC6A4, SRC |
3.9929 |
|
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
3.97566 |
|
[MF] GO:0005329 |
None
|
SLC6A2, SLC6A3, SLC6A4 |
3.85715 |
|
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.70032 |
|
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, TYR |
3.70032 |
|
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.51309 |
|
[MF] GO:0001591 |
None
|
DRD2, DRD3, DRD4 |
3.48883 |
|
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, MAOB, XDH |
3.44631 |
|
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.41738 |
|
[MF] GO:0008504 |
None
|
SLC6A2, SLC6A3, SLC6A4 |
3.36322 |
|
[MF] GO:0042803 |
protein homodimerization activity
|
ACHE, ADRA2A, AOX1, BCL2, DRD2, FLT3, KCNH2, MAOB, SLC6A4, TERT, TOP2A, TYR, XDH |
3.1536 |
|
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, SRC |
3.09779 |
|
[MF] GO:0004952 |
None
|
DRD2, DRD3, DRD4 |
3.02086 |
|
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
2.99024 |
|
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, SRC |
2.95016 |
|
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.94133 |
|
[MF] GO:0005496 |
steroid binding
|
ESR1, ESR2, ESRRA, ESRRB, RORC |
2.839 |
|
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AOX1, XDH |
2.75882 |
|
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, TYR |
2.70605 |
|
[MF] GO:0099583 |
None
|
GRM1, GRM5 |
2.53683 |
|
[MF] GO:0047374 |
None
|
CES1, CES2 |
2.53683 |
|
[MF] GO:0004970 |
None
|
GRIA2, GRIA4, GRIK5 |
2.49093 |
|
[MF] GO:0005234 |
None
|
GRIA2, GRIA4, GRIK5 |
2.49093 |
|
[MF] GO:0005326 |
None
|
SLC1A1, SLC6A2, SLC6A3, SLC6A4 |
2.4704 |
|
[MF] GO:0015370 |
None
|
SLC1A1, SLC6A2, SLC6A3, SLC6A4 |
2.4704 |
|
[MF] GO:0005328 |
None
|
SLC6A2, SLC6A3, SLC6A4 |
2.43861 |
|
[MF] GO:0001223 |
transcription coactivator binding
|
ESR1, PPARA, TERT |
2.43861 |
|
[MF] GO:0046983 |
protein dimerization activity
|
ACHE, ADORA1, ADRA2A, AOX1, AXL, BCL2, DRD2, FLT3, KCNH2, MAOB, SLC6A4, TERT, TOP2A, TYR, XDH |
2.40945 |
|
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.39647 |
|
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, MAOB, SRC, XDH |
2.29995 |
|
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.29995 |
|
[MF] GO:0004971 |
None
|
GRIA2, GRIA4 |
2.29995 |
|
[MF] GO:0032795 |
None
|
ADORA1, ADRA2A |
2.29995 |
|
[MF] GO:0004930 |
None
|
ADORA1, ADORA3, ADRA2A, CHRM2, DRD2, DRD3, DRD4, GRM1, GRM3, GRM5, GRM8, HCAR2 |
2.25676 |
|
[MF] GO:0099094 |
None
|
GRIA2, GRIA4, GRIK5, KCNH2 |
2.22578 |
|
[MF] GO:0016788 |
None
|
ACHE, ADORA1, ALPL, APEX1, CA1, CA2, CDC25B, CES1, CES2, PDE5A, PTPN1 |
2.18803 |
|
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.13444 |
|
[MF] GO:0051380 |
None
|
ADRA2A, DRD4 |
2.13444 |
|
[MF] GO:0051721 |
None
|
BCL2, PTPN1, SLC6A3 |
2.08419 |
|
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, HSD17B2, XDH |
2.07136 |
|
[MF] GO:0008519 |
None
|
SLC6A2, SLC6A3, SLC6A4 |
2.01755 |
|
[MF] GO:0052689 |
carboxylic ester hydrolase activity
|
ACHE, CA1, CA2, CES1, CES2 |
2.0069 |
|
[MF] GO:0004064 |
arylesterase activity
|
CA1, CA2 |
2.00128 |
|
[MF] GO:0043546 |
None
|
AOX1, XDH |
2.00128 |